SIGA has a strong cash balance of $155 million, considering factors like cash flow and market conditions before deciding on special dividends. The company is engaged in discussions with BARDA regarding the importance of tecovirimat for smallpox preparedness.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing